Agent for salting out active principles in dressings containing at least one of fatty substance
View Patent ↗The present invention relates to the use, as an agent for salting out an active substance in a composition for a dressing, of a copolymer of a salt of 2-methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulphonic acid and the 2-hydroxyethyl ester of propenoic acid. It also relates to dressings of the type comprising at least one fatty substance and/or an elastomeric matrix and at least one active substance, which incorporate the aforementioned copolymer.
1. A dressing comprising a mass, wherein the mass comprises a hydrocolloid in an amount of between 2 and 20% by weight of the mass, at least one selected from the group consisting of a fatty substance and an elastomeric matrix, at least one active substance, and a copolymer of a salt of 2-methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid and of 2-hydroxyethylpropenoate ester,
wherein the copolymer is included in an amount sufficient for increasing an amount of the active substance that is released from the dressing as compared to that of a corresponding dressing that does not comprise the copolymer,
wherein the amount of the copolymer included in the dressing is between 1% to 20% by weight, and
wherein the amount of the active substance included in the dressing is between 0.01% and 15% by weight.
2. The dressing as claimed in claim 1 , wherein the salt of 2-methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid is a sodium salt.
3. The dressing as claimed in claim 1 , wherein said active substance is selected from the group consisting of bactericidal agents, bacteriostatic agents, agents for promoting healing, enzymes for promoting wound cleaning, protease inhibitors, metalloprotease inhibitors, painkillers, local anesthetics and nonsteroidal anti-inflammatory drugs.
4. The dressing as claimed in claim 1 , which comprises between 1% and 10% by weight of said copolymer.
5. The dressing as claimed in claim 1 , which comprises between 3% and 8% by weight of said active substance.
6. A method for releasing an active substance from a dressing composition that comprises a mass, wherein the mass comprises a hydrocolloid in an amount of between 2 and 20% by weight of the mass and, at least one selected from the group consisting of a fatty substance and an elastomeric matrix and at least one active substance, the method comprising incorporating a copolymer of a salt of 2-methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid and of 2-hydroxyethylpropenoate ester in said dressing composition in an amount sufficient for increasing an amount of the active substance that is released from the dressing as compared to that of a corresponding dressing that does not comprise the copolymer,
wherein the amount of the copolymer incorporated in the dressing is between 1% to 20% by weight, and
wherein the amount of the active substance included in the dressing is between 0.01% and 15% by weight.
7. The method as claimed in claim 6 , wherein said salt of 2-methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid is a sodium salt.
8. The method as claimed in claim 6 , wherein said active substance is selected from the group consisting of bactericidal agents, bacteriostatic agents, agents for promoting healing, enzymes for promoting wound cleaning, protease inhibitors, metalloprotease inhibitors, painkillers, local anesthetics and nonsteroidal anti-inflammatory drugs.
9. The method as claimed in claim 6 , wherein the composition comprises an elastomeric matrix.
10. The dressing as claimed in claim 3 , wherein said active substance is a bactericidal or bacteriostatic agent.
11. The dressing as claimed in claim 10 , wherein said active substance is selected from the group consisting of: chloramine, chlorhexidine, silver salts, zinc salts, metronidazole and penicillin.
12. The dressing as claimed in claim 11 , wherein said active substance is silver salts or zinc salts.
13. The dressing as claimed in claim 12 , wherein said active substance is silver salts.
14. The dressing as claimed in claim 3 , wherein said active substance is an agent for promoting healing.
15. The dressing as claimed in claim 14 , wherein said active substance is potassium sucrose octasulfate.
16. The dressing as claimed in claim 3 , wherein said active substance is a painkiller or local anesthetic.
17. The dressing as claimed in claim 16 , wherein said active substance is lidocaine or cinchocaine.
18. The dressing as claimed in claim 3 , wherein said active substance is a nonsteroidal anti-inflammatory drug.
19. The dressing as claimed in claim 18 , wherein said active substance is selected from the group consisting of: ibuprofen, ketoprofen, fenoprofen, and diclofenac.
20. The dressing as claimed in claim 1 , wherein the hydrocolloid is at least one selected from the group consisting of pectin, alginate, a natural plant gum, a cellulose derivative or an alkali metal salt thereof, and a superabsorbent.
21. The dressing as claimed in claim 1 , wherein the hydrocolloid is a carboxymethylcellulose or a sodium or calcium salt thereof.
22. The dressing as claimed in claim 21 , wherein the fatty substance is a paraffin oil, petroleum jelly, or a mineral oil formed from compounds of paraffinic, naphthenic or aromatic nature.
23. The dressing as claimed in claim 22 , wherein the active agent is a bacteriostatic silver salt, potassium sucrose octasulfate, lidocaine, cinchocaine, or a non-steroidal antiinflammatory drug.